HITLAB today announced that its partner Rewire DTX, a digital therapeutics company advancing game-based cognitive interventions for depression, has successfully closed a bridge financing round, marking a pivotal step toward clinical deployment and scale.
HITLAB announced today the launch of a new weekly Tuesday virtual series, called Breakthrough Tech Tuesdays, designed to highlight evidence-based healthcare innovation and its real-world clinical impact. This series, which is free and open to all, takes place every Tuesday, bringing together global health technology leaders, researchers, and healthcare executives for timely and applied discussions.
HITLAB today announced a strategic partnership with Sayvant, a digital health company delivering real-time clinical intelligence for acute care. Through this collaboration, HITLAB will support independent evaluation of Sayvant’s platform to help validate its clinical, operational, and financial impact in real-world care settings.
HITLAB today announced a strategic partnership with Prevent Care Health Services, a digital health company transforming how wearable-generated data is translated into real-time, clinically actionable insight across electronic medical records (EMRs) and telehealth platforms.
HITLAB today announced a strategic partnership with Jeeva Clinical Trials, a U.S.-based digital research platform provider delivering a human-centric, AI-native eClinical cloud for decentralized and hybrid clinical trials.
HITLAB announced today the appointment of Divya Verma, Vice President of Business Development at Accord Healthcare, as the new Chair of its Women’s Health Tech Initiative (WHTI)—a major step forward in accelerating innovation for one of the most underfunded and underserved sectors of global healthcare.





